NCT03897192View on ClinicalTrials.gov

Long-term Outcome of Zonal Outer Retinopathy in Punctate Inner Choroidopathy or Multifocal Choroiditis

CompletedOBSERVATIONAL
Enrollment

14

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

January 31, 2019

Study Completion Date

March 20, 2019

Conditions
Punctate Inner Choroidopathy
Interventions
DRUG

Bevacizumab

Anti-vascular endothelial growth factor (VEGF)

Trial Locations (1)

Unknown

Changhua Christian Hospital, Changhua

All Listed Sponsors
lead

Changhua Christian Hospital

OTHER

NCT03897192 - Long-term Outcome of Zonal Outer Retinopathy in Punctate Inner Choroidopathy or Multifocal Choroiditis | Biotech Hunter | Biotech Hunter